E. Chirat

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Xavier Pivot, Gilles Romieu, Marc Debled et al. · The Lancet · 2019 · 125 citations

Breast Oncology, Oncology, Early Breast Cancer +6

Bladder-conserving surgery and interstitial brachytherapy for lymph node negative transitional cell carcinoma of the urinary bladder: results of a 28-year single institution experience

R. de Crevoisier, Aziz Ammor, B Court et al. · Radiotherapy and Oncology · 2004 · 15 citations

Urology, Surgical Oncology, Genitourinary Cancer +8

Esophageal brachytherapy: Institut Gustave Roussy's experience

Manon Kissel, E. Chirat, Pierre Annède et al. · Brachytherapy · 2020 · 11 citations

Esophagus, Esophageal Cancer, Thoracic Surgery +4